Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related…
$2.14+0.47%
报价 2026-11-06
市值
$20.6M
EV
$30.2M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -88.3%
$0.80$18.27
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| EDSAEdesa Biotech, Inc. | $20.6M | +0.5% | – | 0% | – | – | – | |
| CRVOCervoMed Inc. | $21.5M | -2.1% | -91.7% | 100% | – | – | – | |
| ENLVEnlivex Therapeutics Ltd. | $21.4M | -8.6% | – | 0% | 0.0x | – | – | |
| ATOSAtossa Therapeutics, Inc. | $21.2M | +5.0% | +765.1% | 0% | – | – | – | |
| SERSerina Therapeutics, Inc. | $20.7M | -16.4% | 0.0% | 0% | – | – | – | |
| IGCIGC Pharma, Inc. | $20.7M | +5.8% | +25.0% | 21.9% | – | – | – | |
| TAOXTAO Synergies Inc. | $20.4M | +8.3% | – | 99.9% | – | – | – | |
| COCPCocrystal Pharma, Inc. | $20M | +4.0% | -100.0% | 0% | – | – | – | |
| MCRBSeres Therapeutics, Inc. | $19.7M | -5.3% | +133.3% | -20.9% | – | – | – | |
| 同行中位数 | – | – | +12.5% | 0% | 0.0x | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。